Roche's CellCept linked to pure red cell aplasia
This article was originally published in Scrip
Executive Summary
Roche has revised the US labelling for CellCept (mycophenolate mofetil) and distributed a "Dear Health Care Professional" letter to warn that the immunosuppressant can cause pure red cell aplasia, a type of anaemia.